|
Originally published In Press as doi:10.1074/jbc.M200964200 on April 18, 2002
J. Biol. Chem., Vol. 277, Issue 26, 23301-23307, June 28, 2002
Phosphoenolpyruvate Carboxykinase Overexpression Selectively
Attenuates Insulin Signaling and Hepatic Insulin Sensitivity in
Transgenic Mice*
Yang
Sun ,
Sha
Liu ,
Sandra
Ferguson ,
LiQin
Wang ,
Patrick
Klepcyk ,
Jeung S.
Yun§, and
Jacob E.
Friedman ¶
From the Department of Nutrition, Case Western
Reserve University School of Medicine, Cleveland, Ohio 44106-4935 and the § Edison Animal Biotechnology Center, Ohio
University, Athens, Ohio 45107
The ability of insulin to suppress
gluconeogenesis in type II diabetes mellitus is impaired; however, the
cellular mechanisms for this insulin resistance remain poorly
understood. To address this question, we generated transgenic (TG) mice
overexpressing the phosphoenolpyruvate carboxykinase (PEPCK) gene under
control of its own promoter. TG mice had increased basal hepatic
glucose production (HGP), but normal levels of plasma free fatty acids (FFAs) and whole-body glucose disposal during a
hyperinsulinemic-euglycemic clamp compared with wild-type controls. The
steady-state levels of PEPCK and glucose-6-phosphatase mRNAs were
elevated in livers of TG mice and were resistant to down-regulation by
insulin. Conversely, GLUT2 and glucokinase mRNA levels were
appropriately regulated by insulin, suggesting that insulin resistance
is selective to gluconeogenic gene expression. Insulin-stimulated
phosphorylation of the insulin receptor, insulin receptor substrate
(IRS)-1, and associated phosphatidylinositol 3-kinase were normal in TG
mice, whereas IRS-2 protein and phosphorylation were down-regulated compared with control mice. These results establish that a modest (2-fold) increase in PEPCK gene expression in vivo is
sufficient to increase HGP without affecting FFA concentrations.
Furthermore, these results demonstrate that PEPCK overexpression
results in a metabolic pattern that increases glucose-6-phosphatase
mRNA and results in a selective decrease in IRS-2 protein,
decreased phosphatidylinositol 3-kinase activity, and reduced ability
of insulin to suppress gluconeogenic gene expression. However, acute suppression of HGP and glycolytic gene expression remained intact, suggesting that FFA and/or IRS-1 signaling, in addition to reduced IRS-2, plays an important role in downstream insulin signal
transduction pathways involved in control of gluconeogenesis and
progression to type II diabetes mellitus.
*
This work was supported by National Institutes of Health
Grant DK59767.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Pediatrics, Biochemistry, and Molecular Genetics, University of
Colorado Health Sciences Center, Mail Stop B195, 4200 East Ninth Ave., Denver, CO 80262. Tel.: 303-315-5130; Fax: 303-315-3851; E-mail: jed.friedman@UCHSC.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Visinoni, B. C. Fam, A. Blair, C. Rantzau, B. J. Lamont, R. Bouwman, M. J. Watt, J. Proietto, J. M. Favaloro, and S. Andrikopoulos
Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver
Am J Physiol Endocrinol Metab,
November 1, 2008;
295(5):
E1132 - E1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Gomez-Valades, A. Mendez-Lucas, A. Vidal-Alabro, F. X. Blasco, M. Chillon, R. Bartrons, J. Bermudez, and J. C. Perales
Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
Diabetes,
August 1, 2008;
57(8):
2199 - 2210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kumashiro, Y. Tamura, T. Uchida, T. Ogihara, Y. Fujitani, T. Hirose, H. Mochizuki, R. Kawamori, and H. Watada
Impact of Oxidative Stress and Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} in Hepatic Insulin Resistance
Diabetes,
August 1, 2008;
57(8):
2083 - 2091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Thompson, A. M. Norman, S. S. Donkin, R. R. Shankar, M. H. Vickers, J. L. Miles, and B. H. Breier
Prenatal and Postnatal Pathways to Obesity: Different Underlying Mechanisms, Different Metabolic Outcomes
Endocrinology,
May 1, 2007;
148(5):
2345 - 2354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wu, S. A. Khan, L.-J. Peng, H. Li, S. G. Carmella, and A. J. Lange
Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E536 - E543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Lamont, S. Visinoni, B. C. Fam, M. Kebede, B. Weinrich, S. Papapostolou, H. Massinet, J. Proietto, J. Favaloro, and S. Andrikopoulos
Expression of Human Fructose-1,6-Bisphosphatase in the Liver of Transgenic Mice Results in Increased Glycerol Gluconeogenesis
Endocrinology,
June 1, 2006;
147(6):
2764 - 2772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-H. Yao, L. Chen, and B. L. G. Nyomba
Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes
J Appl Physiol,
February 1, 2006;
100(2):
642 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kaidanovich-Beilin and H. Eldar-Finkelman
Long-Term Treatment with Novel Glycogen Synthase Kinase-3 Inhibitor Improves Glucose Homeostasis in ob/ob Mice: Molecular Characterization in Liver and Muscle
J. Pharmacol. Exp. Ther.,
January 1, 2006;
316(1):
17 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fukui, T. Wada, S. Kagawa, K. Nagira, M. Ikubo, H. Ishihara, M. Kobayashi, and T. Sasaoka
Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5'-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice
Diabetes,
July 1, 2005;
54(7):
1958 - 1967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Burgess, N. Hausler, M. Merritt, F. M. H. Jeffrey, C. Storey, A. Milde, S. Koshy, J. Lindner, M. A. Magnuson, C. R. Malloy, et al.
Impaired Tricarboxylic Acid Cycle Activity in Mouse Livers Lacking Cytosolic Phosphoenolpyruvate Carboxykinase
J. Biol. Chem.,
November 19, 2004;
279(47):
48941 - 48949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vuguin, E. Raab, B. Liu, N. Barzilai, and R. Simmons
Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation
Diabetes,
October 1, 2004;
53(10):
2617 - 2622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Fukuda, T. Fukui, H. Atomi, and T. Imanaka
First Characterization of an Archaeal GTP-Dependent Phosphoenolpyruvate Carboxykinase from the Hyperthermophilic Archaeon Thermococcus kodakaraensis KOD1
J. Bacteriol.,
July 15, 2004;
186(14):
4620 - 4627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Collier and D. K. Scott
Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism
Mol. Endocrinol.,
May 1, 2004;
18(5):
1051 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, T. Zhang, and B. L. G. Nyomba
Insulin resistance of gluconeogenic pathways in neonatal rats after prenatal ethanol exposure
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2004;
286(3):
R554 - R559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. E. Peterside, M. A. Selak, and R. A. Simmons
Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats
Am J Physiol Endocrinol Metab,
December 1, 2003;
285(6):
E1258 - E1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Valverde, D. J. Burks, I. Fabregat, T. L. Fisher, J. Carretero, M. F. White, and M. Benito
Molecular Mechanisms of Insulin Resistance in IRS-2-Deficient Hepatocytes
Diabetes,
September 1, 2003;
52(9):
2239 - 2248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Magnuson, P. She, and M. Shiota
Gene-altered Mice and Metabolic Flux Control
J. Biol. Chem.,
August 29, 2003;
278(35):
32485 - 32488.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gao, K. Walder, T. Sunderland, L. Kantham, H. C. Feng, M. Quick, N. Bishara, A. de Silva, G. Augert, J. Tenne-Brown, et al.
Elevation in Tanis Expression Alters Glucose Metabolism and Insulin Sensitivity in H4IIE Cells
Diabetes,
April 1, 2003;
52(4):
929 - 934.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|